Made possible by a charitable contribution from Bayer
Navigation Tip: Click on blue text that’s italicized, underlined and in bold for link to more information.

Greetings!

The COVID-19 Pandemic has surely affected each of us in unique ways. We in Illinois have just had our Shelter in Place order extended to May 30. At the same time nurseries and garden supply stores have been deemed essential business. Our Governor recognizes that we need bread AND roses to thrive.

Men dealing with prostate cancer, and those who love them, face special challenges in the wake of the pandemic. This includes questions of whether to delay treatment, how a caregiver can help a patient when they’re no longer allowed in the hospital, and many more. The Us TOO website has a special section that provides you with materials from our own sources and those of our partners in the prostate cancer care community. It is updated at least once a week, so please check back frequently. Visit www.ustoo.org/covid .

The work of Us TOO continues, albeit remotely, and we are pleased to provide you with some of the latest Prostate Cancer News You Can Use along with the information below that may be of interest to you. Titles of prostate cancer news articles are also listed with a link to the Us TOO web page that provides access to the full text for each article.

NEWS YOU CAN USE ARTICLES:
Please note that the content below lists only the title of the article rather than a direct link to the content. For access to the full article  CLICK HERE .

  • Decipher Prostate RP Identifies Prostate Cancer Patients Likely to Benefit from Hormonal Therapy

  • Prolaris Predicts Which Prostate Cancer Patients Will Benefit from Multimodality Therapy

  • New Findings from University of California Irvine in Prostate Cancer Provides New Insights (Testosterone replacement therapy reduces biochemical recurrence post-radical prostatectomy)

  • Impact of metastatic prostate cancer on human bone marrow

  • Dynamics of the cell-free DNA methylome of metastatic castration resistant prostate cancer during androgen-targeting treatment

  • After prostate removal, where does PSA come from?

MORE NEWS
On Thursday, April 30th at 1 pm Pacific time, the Prostate Cancer Foundation and Us TOO are co-sponsoring a webinar entitled: “Disparities in Prostate Cancer.” You can find more information and register at: https://www.ustoo.org/pcfwebinar20 . I am honored to serve as both a panelist and moderator for this session.

Thank you for all you do in the work against prostate cancer.


Shalom. Salaam. Peace.

Beau Stubblefield-Tave and the Us TOO Team
Beau Stubblefield-Tave , Executive Director
James Hutson, Development Director
Jackie Konieczka, Office Manager
Terri Likowski, Program Director - Support Group Services
Tim Mix, Communications Director